Skip to main content
. 2021 Jul 29;8(18):2101454. doi: 10.1002/advs.202101454

Scheme 1.

Scheme 1

Schematic of the different forms of prodrug conjugates, respectively, and their potential as building blocks to fabricate nanoprodurg as newly emerging cancer therapy formulations under different endogenous/exogenous stimuli, drug connective patterns and biocompatibility.